Departiment of Clinical Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
Departiment of Clinical Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
BMJ Open. 2023 Sep 4;13(9):e074731. doi: 10.1136/bmjopen-2023-074731.
Treatment satisfaction is a significant determinant of quality of care, especially for patients with chronic diseases such as diabetes. Identifying factors that contribute to treatment satisfaction may improve patient outcomes. This study examined treatment satisfaction and determinant factors in patients with diabetes.
A multicentre hospital-based cross-sectional study was conducted between April and July 2022 at selected hospitals in Northwest Ethiopia.
Eligible adult patients with diabetes were included in the study.
Treatment satisfaction was the main outcome and was measured using the Diabetes Treatment Satisfaction Questionnaire, which was valid and reliable in the current sample. A linear regression analysis was used to determine the association between treatment satisfaction scores and independent variables.
Out of the 422 patients approached, 402 (95.3%) participated in the study. Overall, the mean treatment satisfaction score was 17.13 (±3.3) out of 30. Most of the participants had a lower degree of satisfaction with the current treatment (>52%) and its convenience (>63%). More than half of the participants (51.2%) perceived hyperglycaemia most of the time and hypoglycaemia some of the time (64.9%). Treatment satisfaction was influenced by body mass index (BMI) (p<0.01), number of medical conditions and medications (p<0.001), hyperglycaemia perception (p<0.001), healthcare cost coverage (p<0.001), monthly salary (p<0.001), self-monitoring blood glucose (SMBG) (p=0.017), lifestyle modification status (p<0.01), and comorbidity and/or complications (p<0.001).
Treatment satisfaction was low among patients with a higher BMI, a higher number of medical conditions and medications, comorbidities and/or complications, a frequent perception of hyperglycaemia and a lower monthly salary. Interventions addressing specific independent variables might enhance treatment satisfaction.
治疗满意度是医疗质量的重要决定因素，尤其对糖尿病等慢性病患者而言。确定影响治疗满意度的因素可能会改善患者的预后。本研究旨在探讨糖尿病患者的治疗满意度及其决定因素。
这是一项于 2022 年 4 月至 7 月在埃塞俄比亚西北部选定医院进行的多中心医院横断面研究。
纳入研究的患者为符合条件的成年糖尿病患者。
治疗满意度是主要结局指标，采用糖尿病治疗满意度问卷进行评估，该问卷在当前样本中具有有效性和可靠性。采用线性回归分析确定治疗满意度评分与自变量之间的关联。
在 422 名被接触的患者中，有 402 名（95.3%）参与了研究。总体而言，治疗满意度平均得分为 30 分中的 17.13（±3.3）分。大多数参与者对当前治疗（>52%）和其便利性（>63%）的满意度较低。超过一半的参与者（51.2%）经常感到高血糖，偶尔感到低血糖（64.9%）。治疗满意度受到体重指数（BMI）（p<0.01）、医疗条件和药物数量（p<0.001）、高血糖感知（p<0.001）、医疗保健费用覆盖（p<0.001）、月工资（p<0.001）、自我监测血糖（SMBG）（p=0.017）、生活方式改变状况（p<0.01）以及合并症和/或并发症（p<0.001）的影响。
BMI 较高、医疗条件和药物数量较多、合并症和/或并发症、经常感知高血糖以及月工资较低的患者治疗满意度较低。针对特定自变量的干预措施可能会提高治疗满意度。
